Latest Merck Stories

Niacin Causes Serious Unexpected Side-effects, but no Worthwhile Benefits, for Patients who are at Increased Risk of Heart Attacks and Strokes

2013-03-09 12:20:35

SAN FRANCISCO, March 9, 2013 /PRNewswire/ -- Adding extended-release (ER) niacin to statins does not reduce the chances of high risk patients having a heart attack or stroke, Oxford University scientists leading the HPS2-THRIVE study have revealed at the ACC conference in San Francisco today. In addition, the researchers report that the use of ER niacin causes a significant number of different types of serious side effect. Some of these side effects were already known...

Celebrity Chef Leticia Moreinos Schwartz Partners with Merck on Cuida tu Diabetes, Cuida tu Corazon to Cook up Delicious, Diabetes-Friendly Dishes for Hispanics with Type 2 Diabetes

2013-03-08 08:23:15

Increasing prevalence of diabetes among Hispanics in Miami-Dade County WHITEHOUSE STATION, N.J., March 8, 2013 /PRNewswire/ -- Celebrity chef and cookbook author, Chef Leticia Moreinos Schwartz, is partnering with Merck on Cuida tu Diabetes, Cuida tu Corazon (Taking Diabetes to Heart) to educate Hispanics living with type 2 diabetes about including small, but important changes in their lifestyle. Chef Leticia will visit select cities to show the Hispanic community how to make...

Aggressive R&D Initiatives and Innovative Pipelines - Research Report on J&J, Merck, AbbVie, Novartis, and GSK

2013-03-07 08:29:33

NEW YORK, March 7, 2013 /PRNewswire/ -- Today, Investors Alliance announced new research reports highlighting Johnson & Johnson (NYSE: JNJ), Merck & Co., Inc. (NYSE: MRK), AbbVie Inc. (NYSE: ABBV), Novartis AG (NYSE: NVS), and GlaxoSmithKline Plc (NYSE: GSK). Today's readers may access these reports free of charge - including full price targets, industry analysis and analyst ratings - via the links below. Johnson & Johnson Research Report Since the...

Best Penny Stocks Research and Insider Reports: AT&T, Cree, Coca-Cola, Walgreen, Merck, and Best Buy

2013-03-06 08:31:24

HONG KONG, March 6, 2013 /PRNewswire/ -- Pennystocksinsiders.com (PSI) has issued insider trading reports and equity research for the following companies: AT&T (NYSE:T), Cree (NASDAQ:CREE), Coca-Cola (NYSE:KO), Walgreen (NYSE:WAG), Merck (NYSE:MRK), and Best Buy (NYSE:BBY). (Logo: http://photos.prnewswire.com/prnh/20130130/HK50859LOGO ) (Read full report by clicking the link below, you may need to copy and paste the full link to your browser.) Report Highlights:...

Cardiome announces settlement of debt and termination of line of credit with Merck

2013-03-04 08:29:26

VANCOUVER, March 4, 2013 /PRNewswire/ - Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) today announced it has made the final payment to Merck, known as MSD outside the United States and Canada, of $13 million (currency in U.S. dollars) which has been accepted by Merck as full and final settlement of all amounts owing under the line of credit stemming from the companies' collaboration and license agreement for vernakalant, signed in April 2009. Under the terms of the December 10,...

HPS2-THRIVE Trial: Side-Effects Cause A Quarter Of Heart Patients To Stop Treatment

2013-02-27 11:02:12

The largest randomized study of the vitamin niacin in patients with occlusive arterial disease (narrowing of the arteries) has shown a significant increase in adverse side-effects when it is combined with statin treatment. Results from the HPS2-THRIVE study (Heart Protection Study 2 – Treatment of HDL to Reduce the Incidence of Vascular Events), including the reasons patients stopped the study treatment, are published online today (Wednesday) in the European Heart Journal. Niacin has...

Research Reports on Top Stocks: SunPower, Alpha Natural Resources, American International Group, BP, Merck, and Hewlett-Packard

2013-02-20 08:33:59

HONG KONG, Feb. 20, 2013 /PRNewswire/ -- Pennystocksinsiders.com (PSI) has issued insider trading reports and equity research for the following companies: SunPower (NASDAQ:SPWR), Alpha Natural Resources (NYSE:ANR), American International Group (NYSE:AIG), BP (NYSE:BP), Merck (NYSE:MRK), and Hewlett-Packard (NYSE:HPQ). (Logo: http://photos.prnewswire.com/prnh/20130130/HK50859LOGO ) (Read full report by clicking the link below, you may need to copy and paste the full link to your...

DrugRisk NuvaRing Update: Fewer Using Device Amid Warnings, Lawsuits

2013-02-15 23:00:19

The Drug Risk ResourceCenter is the Web’s largest source for information on prescription drug warnings, side effects and legal news. Visit http://www.DrugRisk.com Dallas, TX (PRWEB) February 15, 2013 The birth control safety advocates at DrugRisk.com are alerting those women using NuvaRing contraceptives of new information added to the site which shows several health organizations have warned of blood clot risks from the devices. Also, Merck has reported lower sales of NuvaRing amid...

Pension Fund ABP Settles with Merck in Securities Class Action

2013-02-14 08:30:41

HEERLEN, Netherlands and AMSTERDAM, Feb. 14, 2013 /PRNewswire/ -- The Dutch pension fund Stichting Pensioenfonds ABP ("ABP"), together with three co-lead plaintiffs, has reached a settlement with Merck and certain of its current and former officers and directors, whereby Merck will pay $215 million to resolve a five-year-old securities class action against all of the Merck defendants. This settlement is part of a $688 million total settlement that Merck agreed to with plaintiffs in...

Odyssey Thera, Inc. Announces New Equity Financing and Initiation of Research Contract with Merck

2013-02-14 08:29:56

SAN RAMON, Calif., Feb. 14, 2013 /PRNewswire/ -- Odyssey Thera, Inc., a privately held biotechnology company, announced today a new equity financing and the initiation of a research service contract with Merck, known as MSD outside the U.S. and Canada. Additional participants in this financing include HBM Partners, Burrill & Company, and Lonza. The financing, comprising new funds and debt conversion, totals $2.8M. These funds will be used to support continued advancement and...